<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Inpatient Antimicrobial Guide</title>
<style>
body { font-family: Arial, sans-serif; margin:0; padding:0; display:flex; }
#sidebar { width:250px; background:#f8f8f8; padding:10px; border-right:1px solid #ccc; height:100vh; overflow-y:auto; }
#sidebar h2 { margin-top:0; }
#sidebar ul { list-style:none; padding-left:0; }
#sidebar li { margin:5px 0; cursor:pointer; color:#007BFF; }
#content { flex:1; padding:20px; overflow-y:auto; }
.expandable { background:#e2e2e2; padding:10px; margin:5px 0; cursor:pointer; border-radius:4px; }
.hidden { display:none; }
table { width:100%; border-collapse:collapse; margin:10px 0; }
th, td { border:1px solid #ccc; padding:5px; text-align:left; }
th { background:#f0f0f0; }
</style>
<script>
function showContent(id){
    document.querySelectorAll('#content > div').forEach(s=>s.style.display='none');
    var section = document.getElementById(id);
    if(section) section.style.display='block';
}
function toggleVisibility(id){
    var e = document.getElementById(id);
    e.style.display = (e.style.display === 'block') ? 'none' : 'block';
}
</script>
</head>
<body>

<div id="sidebar">
<h2>Sections</h2>
<ul>
<li onclick="showContent('homepage')">Home</li>
<li onclick="showContent('bacteria')">Bacterial Infections</li>
<li onclick="showContent('fungi')">Fungal Infections</li>
<li onclick="showContent('viruses')">Viral Infections</li>
<li onclick="showContent('pathogen')">Pathogen-Based Guidance</li>
<li onclick="showContent('overview')">Pathogen Overview</li>
<li onclick="showContent('classes')">Antibiotic Classes / Escalation</li>
<li onclick="showContent('references')">References</li>
</ul>
</div>

<div id="content">

<!-- Homepage -->
<div id="homepage">
<div style="text-align:center; margin-top:50px;">
<img src="mutant-icon.png" alt="Mutant Icon" style="width:150px; height:150px; margin-bottom:20px;">
<h1>Inpatient Antimicrobial Guide</h1>
<p>Select a section from the sidebar to view empiric therapy, culture-directed therapy, Gram-stain/diagnostic guidance, pathogen-specific recommendations, and detailed pathogen information.</p>
</div>
</div>

<!-- Bacterial Infections -->
<div id="bacteria" style="display:none">
<h2>Bacterial Infections</h2>

<h3>Gram-Positive Cocci</h3>
<table>
<tr><th>Pathogen</th><th>Empiric Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Streptococcus spp.</td><td>Penicillin G</td><td>12–24 million units/day IV</td><td>10–14 days</td><td>Adjust per culture and sensitivity</td></tr>
<tr><td>Staphylococcus aureus (MSSA)</td><td>Nafcillin/Oxacillin</td><td>2 g IV q4h</td><td>10–14 days</td><td>Monitor renal</td></tr>
<tr><td>MRSA</td><td>Vancomycin</td><td>15 mg/kg IV q12h</td><td>10–14 days</td><td>Monitor trough and renal</td></tr>
<tr><td>Enterococcus spp.</td><td>Ampicillin + Gentamicin</td><td>Ampicillin 2 g IV q4h, Gent 3 mg/kg/day IV</td><td>4–6 weeks</td><td>Adjust renal</td></tr>
</table>

<h3>Gram-Positive Rods</h3>
<table>
<tr><th>Pathogen</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Mycobacterium tuberculosis</td><td>RIPE (Rifampin, Isoniazid, Pyrazinamide, Ethambutol)</td><td>Per guidelines</td><td>6 months</td><td>Directly observed therapy recommended</td></tr>
<tr><td>Corynebacterium spp.</td><td>Vancomycin or Penicillin</td><td>Vancomycin 15 mg/kg IV q12h</td><td>10–14 days</td><td>Depends on species and site</td></tr>
<tr><td>Nocardia spp.</td><td>Trimethoprim-Sulfamethoxazole</td><td>15 mg/kg/day TMP IV/PO</td><td>6–12 months</td><td>Adjust renal; CNS involvement requires higher doses</td></tr>
<tr><td>Clostridium spp.</td><td>Metronidazole</td><td>500 mg IV q8h</td><td>10–14 days</td><td>Include surgery for necrotizing infections</td></tr>
<tr><td>Actinomyces spp.</td><td>Penicillin G</td><td>18–24 million units/day IV</td><td>6–12 months</td><td>Chronic infections often require prolonged therapy</td></tr>
</table>

<h3>Gram-Negative Cocci</h3>
<table>
<tr><th>Pathogen</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Neisseria meningitidis</td><td>Ceftriaxone</td><td>2 g IV q12h</td><td>7 days</td><td>Close contacts require prophylaxis</td></tr>
<tr><td>Neisseria gonorrhoeae</td><td>Ceftriaxone + Azithromycin</td><td>500 mg IM ×1 + 1 g PO ×1</td><td>Single dose</td><td>Adjust if weight >150 kg</td></tr>
<tr><td>Moraxella catarrhalis</td><td>Amoxicillin-clavulanate</td><td>875/125 mg PO BID</td><td>5–7 days</td><td>Common respiratory pathogen</td></tr>
</table>

<h3>Gram-Negative Rods</h3>
<table>
<tr><th>Pathogen</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Enterobacteriaceae</td><td>Cefepime or Meropenem</td><td>2 g IV q8h / 1 g IV q8h</td><td>7–10 days</td><td>Adjust per susceptibility</td></tr>
<tr><td>Burkholderia cepacia</td><td>Meropenem + TMP-SMX</td><td>Meropenem 1 g IV q8h; TMP-SMX 15 mg/kg/day TMP</td><td>10–14 days</td><td>CF patients often affected</td></tr>
<tr><td>Bacteroides spp.</td><td>Metronidazole ± Beta-lactam</td><td>500 mg IV q8h</td><td>7–10 days</td><td>Intra-abdominal source control essential</td></tr>
<tr><td>Prevotella spp.</td><td>Metronidazole</td><td>500 mg IV q8h</td><td>7–10 days</td><td>Often oral anaerobes</td></tr>
</table>

<h3>Aerobes & Anaerobes (Summary Table)</h3>
<table>
<tr><th>Type</th><th>Empiric Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Aerobes (Pseudomonas, Acinetobacter)</td><td>Cefepime / Piperacillin-Tazobactam</td><td>2 g IV q8h / 4.5 g IV q6–8h</td><td>7–10 days</td><td>Adjust per renal and cultures</td></tr>
<tr><td>Anaerobes</td><td>Metronidazole ± Beta-lactam</td><td>500 mg IV q8h</td><td>7–14 days</td><td>Intra-abdominal, dental, soft tissue</td></tr>
</table>

<h3>Intracellular Pathogens</h3>
<table>
<tr><th>Pathogen</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Chlamydia spp.</td><td>Doxycycline</td><td>100 mg PO BID</td><td>7–14 days</td><td>Alternative: Azithromycin</td></tr>
<tr><td>Legionella spp.</td><td>Levofloxacin</td><td>750 mg IV/PO q24h</td><td>10–14 days</td><td>Adjust for renal</td></tr>
<tr><td>Rickettsia spp.</td><td>Doxycycline</td><td>100 mg PO BID</td><td>7–14 days</td><td>Preferred even in adults; start early</td></tr>
<tr><td>Mycoplasma pneumoniae</td><td>Azithromycin</td><td>500 mg PO day 1 → 250 mg PO daily ×4</td><td>5 days</td><td>Alternative: Doxycycline</td></tr>
<tr><td>Coxiella burnetii (Q fever)</td><td>Doxycycline</td><td>100 mg PO BID</td><td>14 days (acute), 18 months (chronic)</td><td>Chronic: add hydroxychloroquine</td></tr>
</table>

</div>

<!-- Fungal Infections -->
<div id="fungi" style="display:none">
<h2>Fungal Infections</h2>

<h3>Candida spp.</h3>
<table>
<tr><th>Species</th><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>C. albicans</td><td>Micafungin</td><td>100 mg IV q24h</td><td>14 days after negative culture</td><td>Remove lines</td></tr>
<tr><td>C. glabrata</td><td>Micafungin</td><td>100 mg IV q24h</td><td>14 days</td><td>Fluconazole resistance common</td></tr>
<tr><td>C. parapsilosis</td><td>Fluconazole</td><td>400 mg IV/PO daily</td><td>14 days</td><td>-</td></tr>
</table>

<h3>Aspergillus spp.</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Voriconazole</td><td>6 mg/kg IV q12h ×1 → 4 mg/kg IV q12h</td><td>6–12 weeks</td><td>Monitor LFTs and levels</td></tr>
</table>

<h3>Cryptococcus spp.</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Amphotericin B + Flucytosine</td><td>AmB 0.7–1 mg/kg IV + Flucytosine 100 mg/kg/day PO</td><td>2 weeks induction → Fluconazole 8–10 weeks</td><td>Monitor renal and CBC</td></tr>
</table>

<h3>Other Fungi (Histoplasma, Coccidioides)</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Itraconazole</td><td>200 mg PO TID ×3 → 200 mg PO daily</td><td>6–12 months</td><td>Adjust per severity</td></tr>
</table>
</div>

<!-- Viral Infections -->
<div id="viruses" style="display:none">
<h2>Viral Infections</h2>

<h3>Influenza A/B</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Oseltamivir</td><td>75 mg PO BID</td><td>5 days</td><td>Start within 48h of symptoms</td></tr>
</table>

<h3>HSV/VZV</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Acyclovir</td><td>5–10 mg/kg IV q8h</td><td>7–14 days</td><td>Adjust renal</td></tr>
</table>

<h3>CMV</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Ganciclovir</td><td>5 mg/kg IV q12h</td><td>14–21 days</td><td>Step-down to oral valganciclovir; monitor CBC & renal</td></tr>
</table>

<h3>Other Viruses (RSV, Adenovirus)</h3>
<table>
<tr><th>Therapy</th><th>Dose</th><th>Duration</th><th>Notes</th></tr>
<tr><td>Supportive care</td><td>-</td><td>-</td><td>Consider antivirals in immunocompromised</td></tr>
</table>
</div>

<!-- Pathogen-Based Guidance -->
<div id="pathogen" style="display:none">
<h2>Pathogen-Based Guidance</h2>
<p>All Gram-stain and culture-directed therapy tables are included above in infections sections. Tap any pathogen table for dosing, duration, and notes.</p>
</div>

<!-- Pathogen Overview -->
<div id="overview" style="display:none">
<h2>Pathogen Overview</h2>

<div class="expandable" onclick="toggleVisibility('overview-GramPositiveCocci')">Gram-Positive Cocci</div>
<div id="overview-GramPositiveCocci" class="hidden">
<ul>
<li><b>Streptococcus:</b> Pharyngeal colonization; endocarditis risk; generally penicillin-susceptible.</li>
<li><b>Staphylococcus aureus:</b> Skin colonization; MRSA risk varies by region; biofilm formation; beta-lactam resistance common.</li>
<li><b>Enterococcus:</b> GI tract; vancomycin-resistant strains increasing; nosocomial infections.</li>
</ul>
</div>

<div class="expandable" onclick="toggleVisibility('overview-GramPositiveRods')">Gram-Positive Rods</div>
<div id="overview-GramPositiveRods" class="hidden">
<ul>
<li><b>Mycobacterium:</b> TB: airborne; slow-growing; multidrug resistance increasing.</li>
<li><b>Corynebacterium:</b> Skin/mucous; mostly non-pathogenic; C. diphtheriae produces toxin.</li>
<li><b>Nocardia:</b> Soil; immunocompromised; pulmonary/CNS infections.</li>
<li><b>Clostridium:</b> Anaerobic, spore-forming; tetanus, botulism, gas gangrene.</li>
<li><b>Actinomyces:</b> Oral/abdominal flora; chronic suppurative infections.</li>
</ul>
</div>

<div class="expandable" onclick="toggleVisibility('overview-GramNegativeCocci')">Gram-Negative Cocci</div>
<div id="overview-GramNegativeCocci" class="hidden">
<ul>
<li><b>Neisseria meningitidis:</b> Respiratory spread; meningitis outbreaks; capsule typing important.</li>
<li><b>Neisseria gonorrhoeae:</b> STI; increasing cephalosporin resistance.</li>
<li><b>Moraxella catarrhalis:</b> Respiratory flora; beta-lactamase common.</li>
</ul>
</div>

<div class="expandable" onclick="toggleVisibility('overview-GramNegativeRods')">Gram-Negative Rods</div>
<div id="overview-GramNegativeRods" class="hidden">
<ul>
<li><b>Enterobacteriaceae:</b> GI tract; ESBL production common; nosocomial risk.</li>
<li><b>Burkholderia:</b> CF patients; intrinsic resistance.</li>
<li><b>Bacteroides:</b> Anaerobic; intra-abdominal infections; beta-lactamase producers.</li>
<li><b>Prevotella:</b> Oral anaerobe; abscess formation.</li>
</ul>
</div>

<div class="expandable" onclick="toggleVisibility('overview-Intracellular')">Intracellular Pathogens</div>
<div id="overview-Intracellular" class="hidden">
<ul>
<li><b>Chlamydia spp.:</b> Intracellular; STIs; respiratory infections.</li>
<li><b>Legionella:</b> Water reservoirs; pneumonia; intracellular growth.</li>
<li><b>Rickettsia:</b> Vector-borne; endothelial infection.</li>
<li><b>Mycoplasma:</b> Respiratory infections; no cell wall.</li>
<li><b>Coxiella burnetii:</b> Q fever; zoonotic; chronic endocarditis in susceptible patients.</li>
</ul>
</div>

<div class="expandable" onclick="toggleVisibility('overview-Fungi')">Fungi</div>
<div id="overview-Fungi" class="hidden">
<ul>
<li><b>Candida:</b> Endogenous colonization; immunocompromised at risk; resistance varies by species.</li>
<li><b>Aspergillus:</b> Environmental; invasive in neutropenia.</li>
<li><b>Cryptococcus:</b> Soil; HIV patients; CNS tropism.</li>
<li><b>Histoplasma/Coccidioides:</b> Endemic mycoses; inhalation; chronic pulmonary risk.</li>
</ul>
</div>

<div class="expandable" onclick="toggleVisibility('overview-Viruses')">Viruses</div>
<div id="overview-Viruses" class="hidden">
<ul>
<li><b>Influenza:</b> Respiratory droplet spread; seasonal; high-risk in elderly/pregnant.</li>
<li><b>HSV/VZV:</b> Latent infection; reactivation common.</li>
<li><b>CMV:</b> Immunocompromised risk; latent infection.</li>
<li><b>RSV, Adenovirus:</b> Respiratory pathogens; inpatient concern mainly in immunocompromised/infants.</li>
</ul>
</div>

</div>

<!-- Antibiotic Classes / Escalation -->
<div id="classes" style="display:none">
<h2>Antibiotic Classes / Escalation</h2>
<table>
<tr><th>Class</th><th>Example Drugs</th><th>Spectrum Notes</th></tr>
<tr><td>Beta-lactams</td><td>Penicillins, Cephalosporins, Carbapenems</td><td>Broad spectrum; some Gram-negative coverage; monitor allergies</td></tr>
<tr><td>Glycopeptides</td><td>Vancomycin</td><td>Gram-positive only; MRSA coverage</td></tr>
<tr><td>Fluoroquinolones</td><td>Levofloxacin, Ciprofloxacin</td><td>Gram-positive and Gram-negative; Pseudomonas coverage varies</td></tr>
<tr><td>Macrolides</td><td>Azithromycin, Clarithromycin</td><td>Intracellular coverage; respiratory pathogens</td></tr>
<tr><td>Metronidazole</td><td>Metronidazole</td><td>Anaerobes only</td></tr>
<tr><td>Polyenes/Azoles</td><td>Amphotericin B, Voriconazole</td><td>Fungal coverage; species dependent</td></tr>
<tr><td>Antivirals</td><td>Acyclovir, Oseltamivir, Ganciclovir</td><td>Virus-specific; dosing critical</td></tr>
</table>
</div>

<!-- References -->
<div id="references" style="display:none">
<h2>References</h2>
<ul>
<li>IDSA Guidelines (Bacterial, Fungal, Viral)</li>
<li>NEJM, JAMA articles on inpatient antimicrobial therapy</li>
<li>Harrison's Principles of Internal Medicine, 21st Edition</li>
<li>UpToDate recommendations (accessed 2025)</li>
<li>CDC, WHO guidelines on endemic pathogens</li>
</ul>
</div>

</div> <!-- End content -->
</body>
</html>
